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Introduction
HTLV I is a retrovirus that can result in decreased
effectiveness of immune response and an increased inci-
dence of coinfections. HTLV I CNS coinfections with
rare clinical manifestations that may relate to impaired
cellular immunity are presented.
Materials and methods
Case1: a 15-year-old patient presented with difficulty in
standing up and walking on her own (following a fall),
with visual disturbances, and refractory epileptic seizures;
travel history included trips to the Caribbean (Isla
Margarita).
Case2: a 24-year-old patient presented with difficulty in
standing up and walking without support, with sudden
hearing loss, peripheral paresthesia, and generalized
weakness, after having experienced grand mal seizures
several days before; travel history included trips to the
Caribbean (her fiancé was captain of a cruise ship), the
Amazon rainforest and Antarctica.
Results
Case1: brain MRI imaging revealed localized, non-Gadoli-
nium enhancing lesions in the right thalamus and occipital
lobe and cortex edema. EBV DNA and HTLV I/II RNA
were detected in the CSF and EBV VCA IgG antibodies in
the serum. Following administration of supportive treat-
ment and gancyclovir IV for EBV encephalitis, the patient
was discharged with residual mobility impairment.
Case2: brain MRI imaging revealed several medium
sized, non-Gadolinium enhancing lesions in the white
matter of both hemispheres (especially in the temporal
lobe). India ink examination and latex agglutination for
Cryptococcus spp. were positive in the CSF. Cryptococ-
cus gattii was consequently isolated from CSF cultures.
HTLV I/II antibodies and HTLV I/II RNA were both
detected in the serum only. Following a 4-month hospita-
lization, the patient was discharged with clinical improve-
ment, but with relative speech and mobility impairment.
Conclusions
Neurologic manifestations can be encountered in HTLV
I/II monoinfected and coinfected patients, regardless of
HAM/TSP. In CNS coinfections, the definite diagnosis for
HAM/TSP cannot be established by current diagnostic
criteria, reflecting the need for further criteria to also
include coinfections. Quantitation of HTLV I/II proviral
load and investigation of factors related to cellular immu-
nity might augment diagnosis and prognosis.
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